
All multiple sclerosis zzso patients should have their treatment profile carefully evaluated as to disease control, optimal therapy, and adverse side effects at every clinical visit, with the goal of safely minimizing disease zzso There is a general consensus among clinicians that therapy should be initiated early in the course of the disease and should be continued indefinitely unless disease activity continues, intolerable side effects zzso patient transitions to a primary progressive course, or more effective and safer drugs become zzso Patients for whom treatment is delayed should be seen at least every 6 months, and therapy should be initiated if new disease activity is zzso zzso resonance imaging is the most practical laboratory test currently available for monitoring ongoing tissue injury and is useful when evaluating the efficacy of a given zzso Four zzso and 2 zzso are currently approved for the treatment of zzso or secondary progressive forms of zzso in addition, various zzso or zzso drugs have been used zzso alone or in zzso in clinical zzso Many issues remain to be resolved in attempting to zzso disease activity in zzso zzso zzso the art of medicine and clinical judgment become important aspects of zzso patient zzso 

